亚宝药业：累计回购公司股份200000股

Group 1 - The core point of the article is that Yabao Pharmaceutical announced a share buyback program, having repurchased a total of 200,000 shares as of July 31, 2025, which represents 0.03% of the company's total share capital [2] Group 2 - The share repurchase was conducted through centralized bidding transactions [2] - The announcement was made on the evening of August 1 [2] - The buyback program is part of the company's strategy to enhance shareholder value [2]